Rachel Abrams

Over the weekend, President Trump said that he would pay members of the military during the government shutdown, tapping into about $8 billion of Pentagon funds.

It would cover the next pay period for more than a million active duty service members.

But it's not clear how long the administration could pay troops if Congress and the White House can't reach a spending deal.

Meanwhile, the Smithsonian Institution said on Sunday that the shutdown has forced it to close its 21 museums and the National Zoo.

Today's episode was produced by Claire Tennis-Getter, Rob Zipko, and Michael Simon-Johnson.

It was edited by Patricia Willans and Ben Calhoun.

It contains music by Rowan Niemisto, Dan Powell, Marion Lozano, Leah Shaw-Dameron, and Alicia Baitube, and was engineered by Alyssa Moxley.

Special thanks to Gabby Sobelman and Aaron Boxerman.

That's it for The Daily.

I'm Rachel Abrams.

See you tomorrow.

From The New York Times, I'm Rachel Abrams, and this is The Daily.

In the last few years, GLP-1 drugs like Ozempic and Zepbound have been radically reshaping the lives of millions of Americans.

They have the power to change everything, from our appetites and our health to the clothes that we buy.

But they also have the power to affect other parts of our lives, how we date, how we see ourselves, even our closest relationships.

Today, my colleague Lisa Miller tells the story of how these drugs upended one couple's marriage and how they dealt with the fallout.

It's Tuesday, October 7th.

Lisa, I don't think it's an understatement to say that we, in 2025, are in the middle of this, what feels like kind of a weight loss revolution in the United States.

And, of course, we're talking about these drugs that everybody's probably heard of, Ozempic, Wegovi, Monjaro.

I think most people know somebody who's been transformed by them.